GIM-3

1 abstract

Abstract
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).
Org: IRCCS Ospedale Policlinico San Martino, Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, UOC Oncologia Medica,